DOCSLIB.ORG

Neurohormones: Major Groups

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neurohormones: Major Groups Neurohormones: Major Groups • Adrenal medulla – Catecholamines • Hypothalamus • Pituitary gland is two glands fused in one • Posterior pituitary is neural tissue and secretes two neurohomones: vasopressin (antidiuretic hormone or ADH) and oxytocin • Anterior pituitary is endocrine tissue and six hormones: prolactin, thyrotropin, adrenocorticotropin, growth hormone, follicle-stimulating hormone, and luteinizing hormon © 2016 Pearson Education, Inc. Figure 7.8a The Pituitary Gland HYPOTHALAMUS The pituitary gland sits in a protected pocket of bone, connected to the brain by a thin stalk. Infundibulum is the stalk that connects the pituitary to the brain. Sphenoid bone Posterior pituitary is an extension of the neural tissue. Anterior pituitary is a true endocrine gland of ANTERIOR POSTERIOR epithelial origin. © 2016 Pearson Education, Inc. Figure 7.8b The Pituitary Gland The anterior pituitary is a true endocrine gland that secretes six classic hormones. Neurohormones from the hypothalamus control release of the anterior pituitary hormones. The hypothalamic hormones reach the anterior pituitary through a specialized region of the circulation called a portal system. Neurons synthesizing HYPOTHALAMUS trophic neurohormones release them into capillaries of the portal system. Capillary bed Portal veins carry the trophic neurohormones Artery directly to the anterior pituitary, where they act on the endocrine cells. POSTERIOR PITUITARY Capillary bed Endocrine cells release their peptide hormones into the second set of ANTERIOR PITUITARY capillaries for distribution to the rest of the body. Veins TO TARGET ORGANS Prolactin Gonadotropins (LH & FSH) ACTH GH TSH Ovary Testis Mammary glands Musculoskeletal system Thyroid gland Adrenal cortex Gonads © 2016 Pearson Education, Inc. Figure 7.8c The Pituitary Gland The posterior pituitary is an extension of the brain that secretes neurohormones made in the hypothalamus. HYPOTHALAMUS Neurohormone is made and packaged in cell body of neuron. Vesicles are transported down the cell. Vesicles containing neurohormone are stored in posterior pituitary. POSTERIOR PITUITARY Vein Neurohormones are released into blood. Oxytocin Vasopressin Ile Gln Phe Gln Asp Tyr Tyr Asp Cys Cys Cys Cys Gly Gly Pro Pro Leu Arg Mammary glands and uterus Kidneys © 2016 Pearson Education, Inc. Figure 7.8c The posterior pituitary is an extension of the brain that secretes neurohormones made in the hypothalamus. Slide 1 HYPOTHALAMUS Neurohormone is made and packaged in cell body of neuron. Vesicles are transported down the cell. Vesicles containing neurohormone are stored in posterior pituitary. POSTERIOR PITUITARY Vein Neurohormones are released into blood. © 2016 Pearson Education, Inc. Figure 7.8c The posterior pituitary is an extension of the brain that secretes neurohormones made in the hypothalamus. Slide 2 HYPOTHALAMUS Neurohormone is made and packaged in cell body of neuron. POSTERIOR PITUITARY © 2016 Pearson Education, Inc. Figure 7.8c The posterior pituitary is an extension of the brain that secretes neurohormones made in the hypothalamus. Slide 3 HYPOTHALAMUS Neurohormone is made and packaged in cell body of neuron. Vesicles are transported down the cell. POSTERIOR PITUITARY © 2016 Pearson Education, Inc. Figure 7.8c The posterior pituitary is an extension of the brain that secretes neurohormones made in the hypothalamus. Slide 4 HYPOTHALAMUS Neurohormone is made and packaged in cell body of neuron. Vesicles are transported down the cell. Vesicles containing neurohormone are stored in posterior pituitary. POSTERIOR PITUITARY © 2016 Pearson Education, Inc. Figure 7.8c The posterior pituitary is an extension of the brain that secretes neurohormones made in the hypothalamus. Slide 5 HYPOTHALAMUS Neurohormone is made and packaged in cell body of neuron. Vesicles are transported down the cell. Vesicles containing neurohormone are stored in posterior pituitary. POSTERIOR PITUITARY Vein Neurohormones are released into blood. © 2016 Pearson Education, Inc. Endocrine Control • A trophic hormone controls the secretion of another hormone • Hypothalamic-hypophyseal (pituitary) portal system • Three integrating centers – Hypothalamic stimulation—from CNS – Anterior pituitary stimulation—from hypothalamic trophic hormones – Endocrine gland stimulation—from anterior pituitary trophic hormones (except prolactin) Cortisol © 2016 Pearson Education, Inc. Endocrine Control • Anterior pituitary hormones control growth, metabolism, and reproduction • Negative feedback loops – Short-loop pathway • Parathyroid – Long-loop pathway • Cortisol © 2016 Pearson Education, Inc. Figure 7.9 Hormones of the Hypothalamic-Anterior Pituitary Pathway © 2016 Pearson Education, Inc. Figure 7.10 The growth hormone pathway © 2016 Pearson Education, Inc. Figure 7.11a Negative feedback in complex endocrine pathways © 2016 Pearson Education, Inc. Figure 7.11b Negative feedback in complex endocrine pathways © 2016 Pearson Education, Inc. Hormone Interactions • Synergism – Combined effect is greater than the sum of individual effects • Permissiveness – Need second hormone to get full effect • Antagonism – One substance opposes the action of another – Competitive inhibitors vs. functional antagonism – Glucagon opposes insulin © 2016 Pearson Education, Inc. Figure 7.12 Synergism © 2016 Pearson Education, Inc. Endocrine Pathologies • Hypersecretion: excess hormone – Caused by tumors or exogenous iatrogenic treatment – Negative feedback may lead to atrophy of gland • Hyposecretion: deficient hormone – Caused by decreased synthesis materials or atrophy – Absence of negative feedback leads to overproduction of trophic hormones © 2016 Pearson Education, Inc. Figure 7.13 Negative feedback from exogenous hormone © 2016 Pearson Education, Inc. Pathologies: Abnormal Receptors • Down-regulation – Decreased number of receptors – Hyperinsulinemia • Receptor and signal transduction abnormalities – Missing or nonfunctional receptors – Androgen insensitivity syndrome – Pseudohypothyroidism © 2016 Pearson Education, Inc. Pathologies: Abnormal Receptors • Diagnosis depends on the complexity of the reflex – Primary pathology due to issues with last endocrine gland in pathway – Secondary pathology due to pituitary gland – Tertiary pathology due to hypothalamus • Example of hypocortisolism due to primary or secondary pathology © 2016 Pearson Education, Inc. Figure 7.14 Hypercortisolism © 2016 Pearson Education, Inc. Figure 7.15 Hypocortisolism © 2016 Pearson Education, Inc. Hormone Evolution • Evolutionary conservation of hormone function • Proteomics – Calcitonin gene-related peptide example • Vestigial – Melanocyte-stimulating hormone example • Comparative endocrinology – Pineal gland and melatonin example – Melatonin plays a role in sleep-wake cycle and internal clock © 2016 Pearson Education, Inc. Figure 7.16-2 The Pineal Gland © 2016 Pearson Education, Inc. Figure 7.16-3 The Pineal Gland © 2016 Pearson Education, Inc. Figure 7.16-4 The Pineal Gland © 2016 Pearson Education, Inc. Summary • Hormones • The classification of hormones • Control of hormone release • Hormone interactions • Endocrine pathologies • Hormone evolution © 2016 Pearson Education, Inc..
Load more

Recommended publications
  • The Immuno-Neuroendocrine Interface
    Amendment history: Erratum (December 2001) Series Introduction: The immuno-neuroendocrine interface Shlomo Melmed J Clin Invest. 2001;108(11):1563-1566. https://doi.org/10.1172/JCI14604. Perspective The CNS and the various endocrine organs are linked in a dynamic manner through networks of reciprocal interactions that allow for both long-term adaptation and short-term shifts in environmental conditions. These regulatory systems embrace the hypothalamus, the pituitary gland, and any of several target glands, including the adrenal gland and the thyroid. Because the anterior pituitary gland secretes at least six key hormones — adrenocorticotropin (ACTH), growth hormone (GH), prolactin (PRL), thyrotropin (TSH), and the gonadotropins follicle stimulating hormone and luteinizing hormone — such diverse parameters as cell integrity, stress responses, growth, development, reproduction, and energy homeostasis are all directly or indirectly under central control (1). In addition, largely because of the dominant role of the hypothalamo-pituitary-adrenal (HPA) axis, inflammation and immunity are also subject to neuroendocrine effects. The articles in this Perspective series explore some of the developmental, physiological, and molecular interactions occurring at the immuno-neuroendocrine interface. Control of pituitary function Three tiers of control subserve regulation of anterior pituitary trophic hormone secretion (2). First, the hypothalamus synthesizes and secretes releasing and inhibiting hormones, which traverse the hypothalamo-pituitary portal system and bind to specific anterior pituitary G protein−linked transmembrane […] Find the latest version: https://jci.me/14604/pdf PERSPECTIVE SERIES Neuro-immune interface Shlomo Melmed, Series Editor SERIES INTRODUCTION The immuno-neuroendocrine interface Shlomo Melmed Cedars-Sinai Research Institute, University of California Los Angeles, School of Medicine, Los Angeles, California 90048, USA.
    [Show full text]
  • Hormonal Regulation of Oligodendrogenesis I: Effects Across the Lifespan
    biomolecules Review Hormonal Regulation of Oligodendrogenesis I: Effects across the Lifespan Kimberly L. P. Long 1,*,†,‡ , Jocelyn M. Breton 1,‡,§ , Matthew K. Barraza 2 , Olga S. Perloff 3 and Daniela Kaufer 1,4,5 1 Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720, USA; [email protected] (J.M.B.); [email protected] (D.K.) 2 Department of Molecular and Cellular Biology, University of California, Berkeley, CA 94720, USA; [email protected] 3 Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94143, USA; [email protected] 4 Department of Integrative Biology, University of California, Berkeley, CA 94720, USA 5 Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada * Correspondence: [email protected] † Current address: Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA 94143, USA. ‡ These authors contributed equally to this work. § Current address: Department of Psychiatry, Columbia University, New York, NY 10027, USA. Abstract: The brain’s capacity to respond to changing environments via hormonal signaling is critical to fine-tuned function. An emerging body of literature highlights a role for myelin plasticity as a prominent type of experience-dependent plasticity in the adult brain. Myelin plasticity is driven by oligodendrocytes (OLs) and their precursor cells (OPCs). OPC differentiation regulates the trajectory of myelin production throughout development, and importantly, OPCs maintain the ability to proliferate and generate new OLs throughout adulthood. The process of oligodendrogenesis, Citation: Long, K.L.P.; Breton, J.M.; the‘creation of new OLs, can be dramatically influenced during early development and in adulthood Barraza, M.K.; Perloff, O.S.; Kaufer, D.
    [Show full text]
  • Hormone Research
    RECENT PROGRESS IN HORMONE RESEARCH Edited by ANTHONY R. MEANS VOLUME 58 The Human Genome and Endocrinology “Recent Progress in Hormone Research” is an annual publication of The Endocrine Society that is published under the editorial auspices of Endocrine Reviews. The Endocrine Society 8401 Connecticut Avenue, Suite 900 Chevy Chase, Maryland 20815 Copyright 2003 by The Endocrine Society All Rights Reserved The reproduction or utilization of this work in any form or in any electronic, mechanical, or other means, now known or hereafter invented, including photocopying or recording and in any information storage or retrieval system, is forbidden, except as may be expressly permitted by the 1976 Copyright Act or by permission of the publisher. ISBN 0–879225-48-4 CONTENTS Senior Author Correspondence Information v 1. A Functional Proteomics Approach to Signal Transduction 1 Paul R. Graves and Timothy A.J. Haystead 2. The Use of DNA Microarrays to Assess Clinical Samples: The Transition from Bedside to Bench to Bedside 25 John A. Copland, Peter J. Davies, Gregory L. Shipley, Christopher G. Wood, Bruce A. Luxon, and Randall J. Urban 3. Gene Expression Profiling for Prediction of Clinical Characteristics of Breast Cancer 55 Erich Huang, Mike West, and Joseph R. Nevins 4. Statistical Approach to DNA Chip Analysis 75 N.M. Svrakic, O. Nesic, M.R.K. Dasu, D. Herndon, and J.R. Perez-Polo 5. Identification of a Nuclear Factor Kappa B-dependent Gene Network 95 Bing Tian and Allan R. Brasier 6. Role of Defective Apoptosis in Type 1 Diabetes and Other Autoimmune Diseases 131 Takuma Hayashi and Denise L.
    [Show full text]
  • Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease
    cells Review Growth Hormone-Releasing Hormone in Lung Physiology and Pulmonary Disease Chongxu Zhang 1, Tengjiao Cui 1, Renzhi Cai 1, Medhi Wangpaichitr 1, Mehdi Mirsaeidi 1,2 , Andrew V. Schally 1,2,3 and Robert M. Jackson 1,2,* 1 Research Service, Miami VAHS, Miami, FL 33125, USA; [email protected] (C.Z.); [email protected] (T.C.); [email protected] (R.C.); [email protected] (M.W.); [email protected] (M.M.); [email protected] (A.V.S.) 2 Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33101, USA 3 Department of Pathology and Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33101, USA * Correspondence: [email protected]; Tel.: +305-575-3548 or +305-632-2687 Received: 25 August 2020; Accepted: 17 October 2020; Published: 21 October 2020 Abstract: Growth hormone-releasing hormone (GHRH) is secreted primarily from the hypothalamus, but other tissues, including the lungs, produce it locally. GHRH stimulates the release and secretion of growth hormone (GH) by the pituitary and regulates the production of GH and hepatic insulin-like growth factor-1 (IGF-1). Pituitary-type GHRH-receptors (GHRH-R) are expressed in human lungs, indicating that GHRH or GH could participate in lung development, growth, and repair. GHRH-R antagonists (i.e., synthetic peptides), which we have tested in various models, exert growth-inhibitory effects in lung cancer cells in vitro and in vivo in addition to having anti-inflammatory, anti-oxidative, and pro-apoptotic effects. One antagonist of the GHRH-R used in recent studies reviewed here, MIA-602, lessens both inflammation and fibrosis in a mouse model of bleomycin lung injury.
    [Show full text]
  • Somatostatin, an Inhibitor of ACTH Secretion, Decreases Cytosolic Free Calcium and Voltage-Dependent Calcium Current in a Pituitary Cell Line
    The Journal of Neuroscience November 1986, &Ii): 3128-3132 Somatostatin, an Inhibitor of ACTH Secretion, Decreases Cytosolic Free Calcium and Voltage-Dependent Calcium Current in a Pituitary Cell Line Albert0 Luini,* Deborah Lewis,t Simon Guild,* Geoffrey Schofield,t and Forrest Weight? *Laboratory of Cell Biology, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, j-Laboratory of Preclinical Studies, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland 20852, and *Experimental Therapeutics Branch, National Institute on Neurological, Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892 Somatostatin is a neurohormone peptide that inhibits a variety (corticotropin releasing factor, vasointestinal peptide, isopro- of secretory responses in different cell types. We have investi- terenol, and forskolin) and to secretagogues independent of CAMP gated the effects of somatostatin on calcium current and intra- formation, such as potassium, 8-bromocyclic AMP, calcium cellular free calcium in AtT-20 cells, a pituitary tumor line in ionophores (Axelrod and Reisine, 1984) and phorbol esters which the inhibitory actions of this peptide have been well char- (Heisler, 1984). Somatostatin blocks the stimulation of secretion acterized. At concentrations similar to those that inhibit adre- by all of these agents (Axelrod and Reisine, 1984; Richardson, nocorticotropic hormone (ACTH) release, somatostatin and its 1983). A previously described mechanism of action of somato- analogs reduced the levels of intracellular free calcium (as mea- statin is the blockade of the secretagogue-evoked stimulation sured by the Quin-2 technique). Nifedipine and other blockers of CAMP synthesis (Heisler et al., 1982). We now report a novel of voltage-dependent calcium channels also reduced cytosolic effect of somatostatin; namely, the inhibition of voltage-depen- calcium levels.
    [Show full text]
  • Neurohormone Secretion Persists After Post-Afterdischarge Membrane Depolarization and Cytosolic Calcium Elevation in Peptidergic Neurons in Intact Nervous Tissue
    The Journal of Neuroscience, October 15, 2002, 22(20):9063–9069 Neurohormone Secretion Persists after Post-Afterdischarge Membrane Depolarization and Cytosolic Calcium Elevation in Peptidergic Neurons in Intact Nervous Tissue Stephan Michel and Nancy L. Wayne Department of Physiology, David Geffin School of Medicine at University of California at Los Angeles, Los Angeles, California 90095 The purpose of this work was to test the hypothesis that an secretion or on the post-AD membrane potential (Vm ) and electrical afterdischarge (AD) causes prolonged elevation in post-AD Ca 2ϩ signal, ruling out a role for extracellular calcium 2ϩ 2ϩ cytosolic calcium levels that is associated with prolonged se- in the post-AD elevation of [Ca ]i. Both Vm and [Ca ]i re- cretion of egg-laying hormone (ELH) from peptidergic neurons turned to baseline well before ELH secretion, such that neither in intact nervous tissue of Aplysia. Using a combination of prolonged membrane depolarization nor prolonged Ca 2ϩ sig- radioimmunoassay measurement of ELH secretion, electro- naling can fully account for the extent of the persistent secre- physiological measurement of membrane potential, and optical tion of ELH. These findings suggest a unique relationship be- imaging of the concentration of intracellular free calcium ions tween membrane excitability, Ca 2ϩ signaling, and prolonged 2ϩ ([Ca ]i ), we verified that there was persistent secretion of ELH neuropeptide secretion. after the end of the AD; this was accompanied by prolonged post-AD membrane depolarization and prolonged post-AD el- Key words: action potential; Aplysia; bag cell neurons; cal- 2ϩ evation in [Ca ]i. Extracellular treatment with the calcium che- cium imaging; calcium signaling; egg-laying hormone; exocyto- lator EGTA had no effect on the pattern or magnitude of ELH sis; membrane potential; neuroendocrine; neurosecretion ϩ Dependence of exocytosis on Ca 2 influx from extracellular fluid in living tissue.
    [Show full text]
  • Acceleration of Ambystoma Tigrinum Metamorphosis by Corticotropin-Releasing Hormone 1 1,2 GRAHAM C
    JOURNAL OF EXPERIMENTAL ZOOLOGY 293:94–98 (2002) RAPID COMMUNICATION Acceleration of Ambystoma tigrinum Metamorphosis by Corticotropin-Releasing Hormone 1 1,2 GRAHAM C. BOORSE AND ROBERT J. DENVER * 1Department of Ecology and Evolutionary Biology,The University of Michigan, AnnArbor,Michigan48109-1048 2 Department of Molecular,Cellular and Developmental Biology,The University of Michigan, Ann Arbor,Michigan 48109-1048 ABSTRACT Previous work of others and ours has shown that corticotropin-releasing hormone (CRH) is a positive stimulus for thyroid and interrenal hormone secretion in amphibian larvae and that activation of CRH neurons may mediate environmental e¡ects on the timing of metamorphosis. These studies have investigated CRH actions in anurans (frogs and toads), whereas there is currently no information regarding the actions of CRH on metamorphosis of urodeles (salamanders and newts). We tested the hypothesis that CRH can accelerate metamorphosis of tiger salamander (Ambystoma tigrinum) larvae. We injected tiger salamander larvae with ovine CRH (oCRH; 1 mg/day; i.p.) and mon- itored e¡ects on metamorphosis by measuring the rate of gill resorption. oCRH-injected larvae com- pleted metamorphosis earlier than saline-injected larvae.There was no signi¢cant di¡erence between uninjected and saline-injected larvae. Mean time to reach 50% reduction in initial gill length was 6.9 days for oCRH-injected animals, 11.9 days for saline-injected animals, and 14.1 days for uninjected controls. At the conclusion of the experiment (day 15), all oCRH-injected animals had completed metamorphosis, whereas by day 15, only 50% of saline-injected animals and 33% of uninjected animals had metamorphosed.
    [Show full text]
  • NIH Public Access Author Manuscript Neuroscience
    NIH Public Access Author Manuscript Neuroscience. Author manuscript; available in PMC 2010 August 18. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Neuroscience. 2004 ; 126(3): 533±540. doi:10.1016/j.neuroscience.2004.03.036. HIPPOCAMPAL CORTICOTROPIN RELEASING HORMONE: PRE- AND POSTSYNAPTIC LOCATION AND RELEASE BY STRESS Y. Chena, K. L. Brunsona, G. Adelmannb, R. A. Bendera, M. Frotscherb, and T. Z. Barama,* aDepartments of Anatomy/Neurobiology and Pediatrics, ZOT 4475, University of California at Irvine, Irvine, CA 92697-4475, USA bInstitute of Anatomy, University of Freiburg, Albertstrasse 17, D-79104 Freiburg, Germany Abstract Neuropeptides modulate neuronal function in hippocampus, but the organization of hippocampal sites of peptide release and actions is not fully understood. The stress-associated neuropeptide corticotropin releasing hormone (CRH) is expressed in inhibitory interneurons of rodent hippocampus, yet physiological and pharmacological data indicate that it excites pyramidal cells. Here we aimed to delineate the structural elements underlying the actions of CRH, and determine whether stress influenced hippocampal principal cells also via actions of this endogenous peptide. In hippocampal pyramidal cell layers, CRH was located exclusively in a subset of GABAergic somata, axons and boutons, whereas the principal receptor mediating the peptide’s actions, CRH receptor 1 (CRF1), resided mainly on dendritic spines of pyramidal cells. Acute ‘psychological’ stress led to activation of principal neurons that expressed CRH receptors, as measured by rapid phosphorylation of the transcription factor cyclic AMP responsive element binding protein. This neuronal activation was abolished by selectively blocking the CRF1 receptor, suggesting that stress-evoked endogenous CRH release was involved in the activation of hippocampal principal cells.
    [Show full text]
  • 1 General Overview of the Endocrine System Questions to Be Thinking
    General Overview of the Endocrine System Questions to be thinking about to help organize your learning of the components of the Endocrine System: Anatomy 1) Where are the different hormone producing cells located? 2) What hormone does a particular type of endocrine cell or neuron produce? General Overview of the Endocrine System Questions to be thinking about to help organize your learning of the components of the Endocrine System: Hormones 1) What is their general chemical structure? 2) How does their structure affect their function? 3) Where are they produced? 4) What environmental or physiological stimuli regulate their production and secretion? 5) Is their production and secretion under direct neural or hormonal control? 6) What are their targets? 7) What effects do they produce on their targets? 8) How do they produce their effects on their targets (how is the signal transduced? i.e. receptor mechanisms) 1 Often endocrine cells are clumped together into a well defined gland (e.g. pituitary, thyroid, adrenal, testes, ovaries), but not always (e.g. gut, liver, lung). Often endocrine cells are clumped together into a well defined gland (e.g. pituitary, thyroid, adrenal, testes, ovaries), but not always (e.g. gut, liver, lung). Remember, it's cells that produce hormones, not glands. Although many glands secrete more than one type of hormone, most neurons or endocrine cells only produce one type of hormone (there are a few exceptions). 2 Some Terminology Neurohormone: a hormone that is produced by a neuron Some Terminology All of the hormones we discuss can be classified as belonging to one of 2 general functional categories: 1] Releasing hormone (or factors) — hormone that acts on endocrine cells to regulate the release of other hormones.
    [Show full text]
  • The Cryptic Gonadotropin-Releasing Hormone Neuronal System Of
    RESEARCH ARTICLE The cryptic gonadotropin-releasing hormone neuronal system of human basal ganglia Katalin Skrapits1*, Miklo´ s Sa´ rva´ ri1, Imre Farkas1, Bala´ zs Go¨ cz1, Szabolcs Taka´ cs1, E´ va Rumpler1, Vikto´ ria Va´ czi1, Csaba Vastagh2, Gergely Ra´ cz3, Andra´ s Matolcsy3, Norbert Solymosi4, Szila´ rd Po´ liska5, Blanka To´ th6, Ferenc Erde´ lyi7, Ga´ bor Szabo´ 7, Michael D Culler8, Cecile Allet9, Ludovica Cotellessa9, Vincent Pre´ vot9, Paolo Giacobini9, Erik Hrabovszky1* 1Laboratory of Reproductive Neurobiology, Institute of Experimental Medicine, Budapest, Hungary; 2Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, Budapest, Hungary; 31st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary; 4Centre for Bioinformatics, University of Veterinary Medicine, Budapest, Hungary; 5Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; 6Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, Budapest, Hungary; 7Department of Gene Technology and Developmental Biology, Institute of Experimental Medicine, Budapest, Hungary; 8Amolyt Pharma, Newton, France; 9Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, Lille, France Abstract Human reproduction is controlled by ~2000 hypothalamic gonadotropin-releasing *For correspondence: [email protected] (KS); hormone (GnRH) neurons. Here, we report the discovery and characterization of additional [email protected] (EH) ~150,000–200,000 GnRH-synthesizing cells in the human basal ganglia and basal forebrain. Nearly all extrahypothalamic GnRH neurons expressed the cholinergic marker enzyme choline Competing interests: The acetyltransferase. Similarly, hypothalamic GnRH neurons were also cholinergic both in embryonic authors declare that no and adult human brains.
    [Show full text]
  • The Endocrine Physiology 2 Inputs That Control Hormone Secretion • Control by Plasma Concentrations of Mineral Ions Or Organic Molecules
    The Endocrine Physiology 2 Inputs that Control Hormone Secretion • Control by Plasma Concentrations of mineral Ions or Organic molecules. For example, absorption of I- iodine ion increase output of thyroxine hormone by thyroid glands. • Control by Neurons – Nervous system can control hormone secretion in 4 ways. 1) Autonomic NS stimulates adrenal medulla to secrete epinephrine 2) Autonomic NS can stimulate or inhibit secretion of a hormone by an endocrine gland 3) neurohormones secreted by hypothalamus pass through blood to anterior pituitary body and influence the secretion of hormones by it. 4) Axons of some neurons of hypothalamus end in posterior pituitary lobe and release their hormones in it. • Control by Other Hormones – when the secretion of a hormone (thyroid stimulating hormone) causes the secretion of another hormone (triodothyronine), the 1st hormone is called a tropic hormone (thyrotropin). Most of these hormones also cause growth of gland (thyroid) secreting the hormone. For this action a tropic hormone is called a trophic hormone. I gave examples in parentheses. Types of Endocrine disorders • Hyposecretion is too little hormone. Primary hyposecretion can be due to partial damage of gland or enzyme deficiency or lack of nutrient in diet or infection etc. Secondary hyposecretion is caused due to deficiency of the tropic hormone though gland is in good condition. • Hypersecretion is too much hormone. It can also be primary or secondary on similar pattern to hyposecretion. • Hyporesponsiveness is reduced responsiveness of target cells to hormone. Most common type of Diabetes mellitus type 2 is caused due to hyporesponsiveness of target cells (muscle cells and adipose tissue).
    [Show full text]
  • Osmoregulation of Vasopressin Secretion Via Activation of Neurohypophysial Nerve Terminals Glycine Receptors by Glial Taurine
    The Journal of Neuroscience, September 15, 2001, 21(18):7110–7116 Osmoregulation of Vasopressin Secretion via Activation of Neurohypophysial Nerve Terminals Glycine Receptors by Glial Taurine Nicolas Hussy, Vanessa Bre` s, Marjorie Rochette, Anne Duvoid, Ge´ rard Alonso, Govindan Dayanithi, and Franc¸ oise C. Moos Laboratoire de Biologie des Neurones Endocrines, Centre National de la Recherche Scientifique (CNRS) Unite´ Mixte de Recherche 5101, Centre CNRS–Institut National de la Sante´ et de la Recherche Me´ dicale de Pharmacologie et d’Endocrinologie, 34094 Montpellier Cedex 5, France Osmotic regulation of supraoptic nucleus (SON) neuron activity minals is confirmed by immunohistochemistry. Their implication depends in part on activation of neuronal glycine receptors in the osmoregulation of neurohormone secretion was as- (GlyRs), most probably by taurine released from adjacent as- sessed on isolated whole neurohypophyses. A 6.6% hypo- trocytes. In the neurohypophysis in which the axons of SON osmotic stimulus reduces by half the depolarization-evoked neurons terminate, taurine is also concentrated in and osmo- vasopressin secretion, an inhibition totally prevented by strych- dependently released by pituicytes, the specialized glial cells nine. Most importantly, depletion of taurine by a taurine trans- ensheathing nerve terminals. We now show that taurine release port inhibitor also abolishes the osmo-dependent inhibition of from isolated neurohypophyses is enhanced by hypo-osmotic vasopressin release. Therefore, in the neurohypophysis, an os- and decreased by hyper-osmotic stimulation. The high osmo- moregulatory system involving pituicytes, taurine, and GlyRs is sensitivity is shown by the significant increase on only 3.3% operating to control Ca 2ϩ influx in and neurohormone release reduction in osmolarity.
    [Show full text]